Holders over time
- EHC
- ELV
| Quarter | EHC | ELV |
|---|---|---|
| Q3 2020 | 10 holders, $1.3bn | 30 holders, $15.0bn |
| Q4 2020 | 11 holders, $1.6bn | 29 holders, $16.7bn |
| Q1 2021 | 13 holders, $1.2bn | 25 holders, $18.6bn |
| Q2 2021 | 16 holders, $1.2bn | 30 holders, $19.4bn |
| Q3 2021 | 18 holders, $1.3bn | 26 holders, $18.5bn |
| Q4 2021 | 13 holders, $1.2bn | 29 holders, $23.3bn |
| Q1 2022 | 12 holders, $1.4bn | 31 holders, $23.9bn |
| Q2 2022 | 12 holders, $1.2bn | 32 holders, $23.3bn |
| Q3 2022 | 13 holders, $914m | 34 holders, $22.6bn |
| Q4 2022 | 11 holders, $1.0bn | 34 holders, $25.5bn |
| Q1 2023 | 8 holders, $811m | 39 holders, $22.5bn |
| Q2 2023 | 14 holders, $1.4bn | 38 holders, $20.6bn |
| Q3 2023 | 16 holders, $1.3bn | 34 holders, $19.8bn |
| Q4 2023 | 11 holders, $1.3bn | 36 holders, $20.3bn |
| Q1 2024 | 14 holders, $1.7bn | 35 holders, $21.3bn |
| Q2 2024 | 10 holders, $1.5bn | 33 holders, $22.1bn |
| Q3 2024 | 14 holders, $1.8bn | 30 holders, $20.2bn |
| Q4 2024 | 17 holders, $1.8bn | 32 holders, $15.9bn |
| Q1 2025 | 11 holders, $1.8bn | 28 holders, $17.1bn |
| Q2 2025 | 16 holders, $2.1bn | 27 holders, $14.8bn |
| Q3 2025 | 21 holders, $2.6bn | 27 holders, $12.7bn |
| Q4 2025 | 17 holders, $2.4bn | 25 holders, $17.0bn |
| Q1 2026 | 17 holders, $2.0bn | 26 holders, $13.6bn |
| Q2 2026 | 13 holders, $2.0bn | 28 holders, $17.7bn |
Encompass Health Corp
- Holders
- 10
- Reported value
- $1.5bn
- Buyers
- 5
- Sellers
- 3
Breadth +2 among 94 comparable managers.
Elevance Health Inc Formerly
- Holders
- 33
- Reported value
- $22.1bn
- Buyers
- 14
- Sellers
- 21
Breadth -7 among 94 comparable managers.
Who holds both, Q2 2024
Both (7)
Arrowstreet Capital LP, Bridgewater Associates LP, Holocene Advisors LP, Invesco Ltd, Janus Henderson Group Ltd, MFS Investment Management, Wellington Management Group LLP
Only EHC (3)
Capital Research Global Investors, Farallon Capital Management LLC, Woodline Partners LP
Only ELV (26)
AllianceBernstein LP, AQR Capital Management LLC, Artisan Partners LP, Baillie Gifford & Co, Balyasny Asset Management LLC, Brevan Howard Capital Management LP, D. E. Shaw & Co., D1 Capital Partners LP, Dodge & Cox, Eisler Capital Management Ltd, ExodusPoint Capital Management LP, Fidelity (FMR LLC), First Eagle Investment Management LLC, Glenview Capital Management LLC, Jane Street Group LLC, Man Group PLC, Marshall Wace LLP, Millennium Management LLC, Moore Capital Management LP, Neuberger Berman Group LLC, Point72 Asset Management LP, Ruane Cunniff & Goldfarb LP, T. Rowe Price Associates Inc, Two Sigma Investments LP, Voloridge Investment Management LLC, and 1 more
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.